Skip to main content
Log in

APOE genotype effects on alzheimer’s disease onset and epidemiology

Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The risk of developing Alzheimer’s disease (AD) is tied most closely to age and appears to follow Gompertzian kinetics. However, specific genetic factors are also linked closely to AD, and the apolipoprotein E (APOE) genotype accounts for as much of 50% of the attributable risk for AD in many populations. This paper reviews the onset, diagnosis, and epidemiology of AD, specifically with regard to the APOE genotype and the interaction of the genotype with age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Arendt T. (2001) Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer’s disease. Int. J. Dev. Neurosci. 19, 231–245.

    Article  PubMed  CAS  Google Scholar 

  • Ashford J. W., Kindy M. S., Shih W.-J., Cool C., Aleem B., Cobb L., et al. Clinical onset of Alzheimer’s disease (AD) is earlier in patients with an APOE ε4 allele. Annual Meeting, Society for Neuroscience, Orlando, FL, 723.4, 2002.

  • Ashford J. W. and Jarvik L. (1985) Alzheimer’s disease: does neuron plasticity predispose to axonal neurofibrillary degeneration? N. Engl. J. Med. 313, 388–389.

    PubMed  CAS  Google Scholar 

  • Ashford J. W. and Mortimer J. A. (2002) Non-familial Alzheimer’s disease is mainly due to genetic factors. J. Alzheimer’s Dis. 4, 169–177.

    Google Scholar 

  • Ashford J. W., Schmitt F., and Kumar V. (1998a) Diagnosis of Alzheimer’s disease, in Advances in the Diagnosis and Treatment of Alzheimer’s Disease, Kumar, V., and Eisdorfer, C., eds., Springer, New York, pp. 111–151.

    Google Scholar 

  • Ashford J. W., Mattson M., and Kumar V. (1998b) Neurobiological systems disrupted by Alzheimer’s disease and molecular neurobiological theories of vulnerability, in Advances in the Diagnosis and Treatment of Alzheimer’s Disease, Kumar, V., and Eisdorfer, C., eds., Springer, New York, pp. 53–89.

    Google Scholar 

  • Ashford J. W., Shan M., Butler S., Rajesekar A., and Schmitt F. (1995) Temporal quantification of Alzheimer’s disease severity: ‘Time Index Model’. Dementia 6, 269–280.

    Article  PubMed  CAS  Google Scholar 

  • Ashford J. W., Shih W.-J., Coupal J., Shetty R., Schneider A., Cool C., et al. (2000) Single SPECT measures of cerebral cortical perfusion reflect “Time-Index” estimation of dementia severity in Alzheimer’s disease. J. Nuclear Med. 41, 57–64.

    CAS  Google Scholar 

  • Blacker D., Haines J. L., Rodes L., Terwedow H., Go R. C. P., Harrell, L. E., et al. (1997) ApoE-4 and age at onset of Alzheimer’s disease: The NIMH genetics initiative. Neurology 48, 139–147.

    PubMed  CAS  Google Scholar 

  • Blessed G., Tomlinson B. E., Roth M. (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry 114, 797–811.

    Article  PubMed  CAS  Google Scholar 

  • Breitner J. C. S., Wyse B. W., Anthony J. C., Welsh-Bohmer K., Steffens D. C., Norton M. C., et al. (1999) APOE-ε4 count predicts age when prevalence of AD increases, then declines: The Cache County Study. Neurology 53, 321–331.

    PubMed  CAS  Google Scholar 

  • Codemo A., Corti M. C., Mazzetto G., Varotto S., Cortella I., Crepaldi G., and Gabelli C. (2000) Education, APOE status and cognitive impairment in the elderly: an epidemiological study in a rural setting. Neurobiol. Aging 21, S246.

    Google Scholar 

  • Corbo R. M. and Scacchi R. (1999) Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrify’ allele? Ann. Hum. Genet. 63, 301–310.

    Article  PubMed  CAS  Google Scholar 

  • Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923.

    Article  PubMed  CAS  Google Scholar 

  • Dean C., Leakey M. G, Reid D., Schrenk F., Schwartz G. T., Stringer C., and Walker A. (2001) Growth processes in teeth distinguish modern humans from Homo erectus and earlier hominins. Nature 414, 628–631.

    Article  PubMed  CAS  Google Scholar 

  • Evans D. A., Beckett L. A., Field T. S., Feng L., Albert M. S., Bennett D. A., et al. (1997) Apolipoprotein E ε4 and incidence of Alzheimer disease in a community population of older persons. JAMA 277, 822–824).

    Article  PubMed  CAS  Google Scholar 

  • Farrer L. A., Cupples L. A., Haines J. L., Hyman B., Kukull W. A., Mayeux R., et al. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA 278, 1349–1356.

    Article  PubMed  CAS  Google Scholar 

  • Folstein M. F., Folstein S. E., and McCugh P. R. (1975) “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189–198.

    Article  PubMed  CAS  Google Scholar 

  • Frisoni G. B., Louhiha J., Geroldi C., and Trabucchi M. (2001) Longevity and the epsilon 2 allele of apolipoprotein E: the Finnish Centenarians Study. J. Gerontol. A Biol. Sci. Med. Sci. 56, M75-M78.

    PubMed  CAS  Google Scholar 

  • Fullerton S. M., Clark A. G., Weiss K. M., Nickerson D. A., Taylor S. L., Stengard J. H., et al. (2000) Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am. J. Hum. Genet. 67, 881–900.

    Article  PubMed  CAS  Google Scholar 

  • Ganguli M., Chandra V., Kamboh I., Johnston J. M., Dodge H. H., Thelma B. K., et al. (2000) Apolipoprotein E polymorphism and Alzheimer’s disease: the Indo-US Cross-National Dementia Study, Arch. Neurol. 57, 824–830.

    Article  PubMed  CAS  Google Scholar 

  • Guo Z., Fratiglioni L., Viitanen M., Lannfelt L., Basun, H., Fastbom J., and Winblad B. (2001) Apolipoprotein E genotypes and the incidence of Alzheimer’s disease among persons aged 75 years and older: variation by use of anti-hypertensive medication? Am. J. Epidemiol. 153, 225–231.

    Article  PubMed  CAS  Google Scholar 

  • Hendrie H. C., Ogunniyi A., Hall K. S., Baiyewu O., Unverzagt F. W., Gureje O., et al. (2001) Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA 285, 739–747.

    Article  PubMed  CAS  Google Scholar 

  • Hirsch H. R. (1994) Can an improved environment cause maximum lifespan to decrease? Comments of lifespan criteria and longitudinal Gompertzian analysis. Exp. Gerontol. 29, 119–137.

    Article  PubMed  CAS  Google Scholar 

  • Hirsch H. R. (1995) Do intersections of mortality-rate and survival functions have significance? Exp. Gerontol. 30, 147–167.

    Article  PubMed  CAS  Google Scholar 

  • Jarvik G. P., Wijsman E. M., Kukull W. A., Schellenberg G. D., Yu C., and Larson E. B. (1995) Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer’s disease: a case-control study. Neurology 45, 1092–1096.

    PubMed  CAS  Google Scholar 

  • Jick H., Zornbert G. L., Jick S. S., Seshadri S., and Drachman D. A. (2000) Statins and the risk of dementia. Lancet 356, 1627–1631.

    Article  PubMed  CAS  Google Scholar 

  • Koudinov A. R. and Koudinova N. V. (2001) Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J. 10, 1858–1869.

    Google Scholar 

  • Lehmann D. J., Williams J., McBroom J., and Smith A. D. (2001) Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer’s disease and to identify high-risk subgroups. Neuroscience 108, 541–554.

    Article  PubMed  CAS  Google Scholar 

  • Liu H. C., Hong C. J, Wang S. J., Fuh J. L., Wang P. N., Shyu H. Y., and Teng E. L. (1999) ApoE genotype in relation to AD and cholesterol; a study of 2,326 Chinese adults. Neurology 53, 962–966.

    PubMed  CAS  Google Scholar 

  • Mauch D. H., Nagler K., Schumacher S., Goritz C., Muller E.-C., Otto A., and Pfrieger F. W. (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354–1357.

    Article  PubMed  CAS  Google Scholar 

  • Mendiondo M. S., Ashford J. W., Kryscio R. J., Schmitt F. A. (2003) Designing a Brief Alzheimer Screen (BAS). J. Alzheimers Dis. 5, 391–398.

    PubMed  Google Scholar 

  • Mesulam M. M. (1999) Neuroplasticity failure in Alzheimer’s disease: bridging the gap between plaques and tangles. Neuron 24, 521–529.

    Article  PubMed  CAS  Google Scholar 

  • Miech R. A., Breitner J. C., Zandi P. P., Khachaturian A. S., Anthony J. C., Mayer L. (2002) Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology 58, 209–218.

    PubMed  CAS  Google Scholar 

  • Myers R. H., Schaefer E. J., Wilson P. W. F., D’Agostino R., Ordovas J. M., Espino A., et al. (1996) Apolipoprotein E ε4 association with dementia in a population-based study: the Framingham Study. Neurology 46, 673–677.

    PubMed  CAS  Google Scholar 

  • Ohm T. G., Scharnagl H., Marz W., and Bohl J. (1999) Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer’s disease-related lesions. Acta Neuropathol. 98, 273–280.

    Article  PubMed  CAS  Google Scholar 

  • Oppenheimer S. (2003) The Real Eve: Modern Man’s Journey Out of Africa. Carroll and Graf Publishers, New York.

    Google Scholar 

  • Perls T. T., Morris J. N., Ooi W. L., and Lipsitz L. A. (1993) The relationship between age, gender and cognitive performance in the very old: the effect of selective survival. J. Am. Geriatr. Soc. 41, 1193–1201.

    PubMed  CAS  Google Scholar 

  • Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G., and Kokmen E. (1999) Mild cognitive impairment, clinical characterization and outcome. Arch. Neurol. 56, 303–308.

    Article  PubMed  CAS  Google Scholar 

  • Roses A. D. (1995) Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer’s disease. Ann. Neurol. 38, 6–14.

    Article  PubMed  CAS  Google Scholar 

  • Roses A. D. (1996) Apolipoprotein E: alleles as risk factors in Alzheimer’s disease. Annu. Rev. Med. 47, 387–400.

    Article  PubMed  CAS  Google Scholar 

  • Roses A. D. (1997) Apolipoprotein E: a gene with complex biological interactions in the aging brain. Neurobiol Dis. 4, 170–85.

    Article  PubMed  CAS  Google Scholar 

  • Sacher G. A. (1977) Life table modification and life prolongation, in The Handbook of the Biology of Aging, Finch, C. E., and Hayflick, L., eds., Van Nostrand Reinhold, New York, pp. 582–638.

    Google Scholar 

  • Saunders A. M., Strittmatter W. J., Schmechel D., St. George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., et al. (1993) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43, 1467–1472.

    PubMed  CAS  Google Scholar 

  • Seshadri S., Drachman D. A., and Lippa C. F. (1995) Apolipoprotein E ε4 allele and the lifetime risk of Alzheimer’s disease: what physicians know, and what they should know. Arch. Neurol. 52, 1074–1079.

    PubMed  CAS  Google Scholar 

  • Shih W.-J., Ashford J. W., Stipp V., Magoun S. L., Coupal J. J., and Gross K. K. (1999) Consecutive brain SPECT surface three-dimensional displays show progression of cerebral cortical abnormalities in Alzheimer’s disease. Clin. Nuclear Med. 24, 773–777.

    Article  Google Scholar 

  • Slooter A. J. C., Cruts M., Kalmijn S., Hofman A., Breteler M. M. B., Van Broeckhoven C., and van Duijn C. M. (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch. Neurol. 55, 964–968.

    Article  PubMed  CAS  Google Scholar 

  • Strehler B. L. (1977) Time, Cells, and Aging, Academic Press, New York.

    Google Scholar 

  • Stringer C. (2002) Modern human origins: progress and prospects. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 357, 563–579.

    Article  PubMed  Google Scholar 

  • Warwick Daw E., Payami H., Nemens E. J., Nochlin D., Bird T. D., Schellenberg G. D., and Wijsman E. M. (2000) The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet. 66, 196–204.

    Article  Google Scholar 

  • Winnock M., Letenneur L., Jacqmin-Gadda H., Dallongeville J., Amouyel P., and Dartigues J. F. (2002) Longitudinal analysis of the effect of apolipoprotein E ε4 and education on cognitive performance in elderly subjects: the PAQUID study. J. Neurol. Neurosurg. Psychiatry. 72, 794–797.

    Article  PubMed  CAS  Google Scholar 

  • Wilson P. W. F., Schaefer E. J., Larson M. G., and Ordovas J. M. (1996) Apolipoprotein E alleles and risk of coronary disease. Arterioscler. Thromb. Vasc. Biol. 16, 1250–1255.

    PubMed  CAS  Google Scholar 

  • Wolozin B., Kellman W., Ruosseau P., Celesia G. G., and Siegal G. (2000) Decreased prevalence of Alzheimer’s disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57, 1439–1443.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Wesson Ashford.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ashford, J.W. APOE genotype effects on alzheimer’s disease onset and epidemiology. J Mol Neurosci 23, 157–165 (2004). https://doi.org/10.1385/JMN:23:3:157

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/JMN:23:3:157

Index Entries

Navigation